Pharmaceuticals & Therapeutics

AXE's viral 'wiener man' wasn't just a gag. It was a calculated play for attention in the crowded World Cup market, redefining brand engagement.

Healthcare firm Cosmos Health is diversifying into the crowded skincare market with a DTC brand. Can its science-first approach disrupt the beauty industry?

A probiotic brand's $1M TikTok Shop event wasn't just a sales blitz. It's a calculated move proving social commerce is the new gateway to retail giants.

Allbirds' IP finds new life with licensing experts, while its former parent company sheds its footwear past to chase an AI future as 'Smartbird'.

A Michigan ear clinic's new partnership reveals a seismic shift in healthcare. Private equity and MSOs promise growth, but what does this mean for doctors?

A Florida hospital just rebuilt a baby's heart in stages. It's not just a medical first; it's a new blueprint for innovation where execution trumps hype.

Melanie Krinsky’s visionary approach to finance has funneled billions into entertainment, backing indie hits and reshaping how creativity gets funded.

AB Science has secured a US patent until 2042 for masitinib, a targeted therapy for advanced prostate cancer, offering new hope where few options exist.

As RESTEM presents at BIO 2026, the company showcases its novel cell therapies aiming to reprogram the immune system, not just manage symptoms.

PawCo's arrival on Chewy is more than a distribution deal. It's a calculated move at the intersection of food science, AI, and sustainability.

Beyond the VivaTech hype, Rokid's strategic partnership with French retail giant Krys reveals a calculated plan to tackle AR's biggest adoption hurdles.

A new network aims to speed up clinical trials by recruiting patients from med spas and longevity clinics. Is this the future of medicine or a risky new frontier?

A Japanese tech firm is uniting global textile titans to reinvent wool. Discover how the 'PLATINUMWORLD' alliance is weaving a new industrial model.

Beyond new flavors, Beech-Nut’s latest launch is a calculated play for the modern parent, blending on-the-go convenience with key developmental milestones.

As overdose deaths skyrocket among Black and Indigenous communities, a new webinar confronts the systemic failures and charts a course for equitable care.

With a novel FDA clearance for its at-home UVB device, Solius Labs isn't just launching a product; it's creating a new market for personalized medicine.

A new report reveals which cannabis brands dominate AI search, just as federal rescheduling creates chaos and opportunity. But with AI often refusing to answer, who wins?

A landmark victory at the 2026 Autoflower World Cup validates 42 Fast Buds' strategic pivot to in-house cultivation, setting a new benchmark for the industry.

Hearst and NYU Langone's star-studded Health Lab reveals a strategic pivot from fitness to holistic wellness, tapping a new market of longevity and vulnerability.

Chronic fatigue, anxiety, and burnout are surging. A new wave of data-driven, integrative medicine claims to have the answer, moving beyond symptoms to the root cause.